Skip to main content

Table 1 Clinicopathological characteristics of the study cohort

From: Classical and non-classical HLA class I aberrations in primary cervical squamous- and adenocarcinomas and paired lymph node metastases

Clinicopathological characteristics

SCC

AC

P - value

Number of patients

103

33

–

Age

0.103(#)

 Mean

44.25

41.39

 Min

24

23

 Max

81

72

FIGO stage

0.856

 IBI

60 (58.2)

20 (60.6)

  > = IBII

42 (40.8)

13 (39.4)

 

 Missing

1 (1)

0 (0.0)

Tumor size

0.448

  < =4 cm

72 (69.9)

25 (75.8)

  > 4 cm

29 (28.2)

7 (21.2)

 Missing

2 (1.9)

1 (3.0)

Vaginal involvement

0.191*

 Yes

17 (16.5)

1 (3.0)

 No

84 (81.6)

22 (66.7)

 Missing

2 (1.9)

10 (30.3)

Parametrium invasion

0.122

 Yes

38 (36.9)

7 (21.2)

 No

63 (61.2)

24 (72.7)

 Missing

2 (1.9)

2 (6.1)

Progression

0.303

 Yes

32 (31.1)

13 (39.4)

 No

65 (63.1)

14 (42.4)

 Missing

6 (5.8)

6 (18.2)

Recurrence in 5 years

0.014

 Yes

30 (29.1)

18 (54.5)

 No

64 (62.1)

14 (42.4)

 Missing

9 (8.7)

1 (3.0)

  1. Progression: determined by physical examination, pathological or radiological assessment
  2. Recurrence: recurrence after a complete remission due to the treatment
  3. P-value measured with Asymptotic Pearson Chi2; (*)Exact test was used when counts were less than 5; (#)Mann-Whitney U Test was used for mean comparison
  4. Data shown as n (%)
  5. FIGO International Federation of Gynecology and Obstetrics, SCC squamous cell carcinoma, AC adenocarcinoma